Showing results (1821-1830 of 3,159) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|May 12, 2004
Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapyWeizhen Xu, Anna Janss, Roger J Packer, et al.
Neuro-Oncology|May 12, 2004
Refining the staging evaluation of pineal region germinoma using neuroendoscopy and the presence of preoperative diabetes insipidusAlyssa T Reddy, John C Wellons, Jeffrey C Allen, et al.
Neuro-Oncology|May 12, 2004
Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant gliomaJennifer A Quinn, David A Reardon, Allan H Friedman, et al.
Neuro-Oncology|April 16, 2005
Phase 2 study of T138067-sodium in patients with malignant glioma: Trial of the National Cancer Institute of Canada Clinical Trials GroupSarah Kirby, Stan Z Gertler, Warren Mason, et al.
Neuro-Oncology|October 11, 2005
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesisRoger Abounader, John Laterra
Neuro-Oncology|October 11, 2005
Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variablesYi-Hong Zhou, Kenneth R Hess, Longjian Liu, et al.
Neuro-Oncology|October 5, 2006
The course of neurocognitive functioning in high-grade glioma patientsIngeborg Bosma, Maaike J Vos, Jan J Heimans, et al.
Neuro-Oncology|August 2, 2005
Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivoAntonietta Arcella, Giulia Carpinelli, Giuseppe Battaglia, et al.
Neuro-Oncology|December 1, 2022
Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classificationJeffrey A Zuccato, Vikas Patil, Sheila Mansouri, et al.
Neuro-Oncology|December 13, 2022
Changes in outcomes and factors associated with survival in melanoma patients with brain metastasesMerve Hasanov, Denái R Milton, Alicia Bea Davies, et al.
Pageof 316